Beyond sun protection factor testing

International Journal of Cosmetic Science

Volumn 26, Issue 4, 2004, Pages 207-214

  Rhodes, L E ^a   Callaghan, T M ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Hill Top Research Inc   (United Kingdom)

Author keywords

Application technique; Polymorphic light eruption; Sun protection factor; Sunscreens; UVA protection

Indexed keywords

ALPHA GLYCOSYLRUTIN PLUS TOCOPHEROL ACETATE PLUS FERULIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FISH OIL; MEXORYL SX; OMEGA 3 FATTY ACID; STEROID; SUNSCREEN; UNCLASSIFIED DRUG; UVISTAT ULTRABLOCK 30;

AGING; ARTICLE; CARCINOGENESIS; ERYTHEMA; HUMAN; IMMUNE DEFICIENCY; PHOTOSENSITIVITY; PHOTOSENSITIVITY DISORDER; PHOTOTHERAPY; POLYMORPHIC LIGHT ERUPTION; PREVALENCE; SKIN PROTECTION; SUNBURN; SUNLIGHT PROTECTION; TECHNIQUE; TREATMENT FAILURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

EID: 4143056997     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-2494.2004.00222.x     Document Type: Article

References (44)

1. Rhodes, L.E. Topical and systemic approaches for protection against solar radiation-induced skin damage. Clin. Derm. 16, 75-82 (1998).
2. Vainio H. and Bianchini F., eds. In: IARC Handbooks of Cancer Prevention. Vol. 5: Sunscreens. World Health Organization, International Agency for Research on Cancer, Lyon, France (2001).
3. Kelly, D.A., Seed, P.T., Young, A.R. and Walker, S.L. A commercial sunscreen's protection against ultraviolet radiation-induced immunosuppression is more than 50% lower than protection against sunburn in humans. J. Invest. Derm. 120, 65-71 (2003).
4. DeGruijl, F.R., Steerenborg, H.J.C.M., Forbes, P.D. et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 53, 53-60 (1993).
5. National Radiological Protection Board. Health Effects from Ultraviolet Radiation. Report of an Advisory Group on Non-ionising Radiation. Documents of the National Radiological Protection Board, 13, (2002).
6. Green, A., Williams, G., Neale, R. et al. Daily sunscreen application and beta-carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354, 723-729 (1999).
7. Thompson, S.C., Jolley, D. and Marks, R. Reduction of solar keratoses by regular sunscreen use. N. Engl. J. Med. 329, 1147-1151 (1993).
8. Duval, C., Schmidt, R, Regnier, M. et al. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp. Dermatol. 12(Suppl. 2), 64-70 (2003).
9. Gillies, R., Moyal, D., Forestier, S. et al. Non-invasive in vivo determination of UV-A efficacy of sunscreens using diffuse reflectance spectroscopy. Photoderm. Photoimmunol. Photomed. 19, 190-194 (2003).
10. Bernerd, F., Vioux, C., Lejeune, F. et al. The sun protection factor (SPF) inadequately defines broad spectrum photoprotection: demonstration using skin reconstructed in vitro exposed to UVA, UVB or UV-solar simulated radiation. Eur. J. Dermatol. 13, 242-249 (2003).
11. Ponten, F., Berne. B., Ren, Z.P. et al. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J. Invest. Dermatol. 105, 402-406 (1995).
12. Poon, T.S., Barnetson, R.S. and Halliday, G.M. Prevention of immunosuppression by sunscreens in humans in unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. J. Invest. Dermatol. 121, 184-190 (2003).
13. Moyal, D and Fourtanier, A. Efficacy of broad spectrum sunscreens against the suppression of elicitation of delayed type hypersensitivity in humans depends upon level of UV-A protection. Exp. Dermatol. 12, 153-159 (2003).
14. Morison, W.L. and Stern, R.S. Polymorphous light eruption: a common reaction uncommonly recognised. Acta Dermatovener (Stockholm) 62. 237-240 (1982).
15. Ros, A. and Wennersten, G. Current aspects of polymorphous light eruptions in Sweden. Photodermatology 3, 298-302 (1986).
16. Pao, C., Morris, P.G., Corbett, M. et al. Polymorphic light eruption: prevalence in Australia and England. Br. J. Dermatol. 130, 62-64 (1994).
17. Norris, P.G. and Hawk, J.L.M. The idiopathic photodermatoses. Polymorphic light eruption, actinic prurigo and hydroa vacciniforme. In: Photodermatology (Hawk, J.L.M. ed.), pp. 103-111. Arnold Publishers. London (1999).
18. Palmer, R.A and Friedmann, P.S. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J. Invest. Dermatol. 122, 291-294 (2004).
19. van Pas, C.B., Kelly, D.A., Seed, P.T. et al. Ultraviolet radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J. Invest. Dermatol. 122, 295-299 (2004).
20. Ling, T.C., Gibbs, N.K. and Rhodes, L.E. Treatment of Polymorphic Light Eruption. Photodermatol. Photoimmunol. Photomed. 19, 217-227 (2003).
21. Eberlein-Konig, B., Fesq, H., Abeck, D. et al. Systemic vitamin C and vitamin E do not prevent photoprovocation test reactions in polymorphous light eruption. Photodermatol. Photoimmunol. Photomed. 16, 50-52 (2000).
22. 2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J. invest. Dermatol. 105, 532-535 (1995).
23. Rhodes, L.E., Shahbakhti, H., Azurdia, R.M. et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis 24, 919-925 (2003).
24. Hadshiew, I., Stab, F., Untiedt, S. et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 195, 362-368 (1997).
25. Rippke, P., Wendt, G., Bohnsack, K. et al. Results of photoprovocation and field studies on the efficacy of a novel topically applied antioxidant in polymorphous light eruption. J. Dermatol. Treat. 12, 3-8 (2001).
26. Farr, P.M. and Diffey, BX. Adverse effects of sunscreens in photosensitive patients. Lancet 1, 429-431 (1989).
27. Stege, H., Budde, M., Grether-Beck, S. et al. Sunscreens with high SPF values are not equivalent in protection from UVA induced polymorphous light eruption. Eur. J. Dermatol. 12, IV-VI (2002).
28. Proby, C., Baker, C., Morton, O. and Hawk, J.L.M. New broad-spectrum sunscreen for polymorphic light eruption. Lancet 341, 1347-1348 (1993).
29. Allas, S., Lui, H., Moyal, D. and Bissonnette, R. Comparison of the ability of 2 sunscreens to protect against polymorphous light eruption induced by a UV-A/UV-B metal halide lamp. Arch. Dermatol. 135, 1421-1422 (1999).
30. Stenberg, C. and Larkö, O. Sunscreen application and its importance for the sun protection factor. Arch. Dermatol. 121, 1300-1402 (1985).
31. Loesch, H. and Kaplan, D.L. Pitfalls in sunscreen application. Arch. Dermatol. 130, 665-666 (1994).
32. Rhodes, L.E. and Diffey, B.L. Quantitative assessment of sunscreen application technique by in vivo fluorescence spectroscopy. J. Soc. Cosmet. Chem. 47, 109-115 (1996).
33. Bech-Thomsen, N. and Wulf, H.C. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol. Photoimmunol. Photomed. 9, 242-244 (1992).
34. Azurdia, R.M., Pagliaro, J.A., Diffey, B.L. and Rhodes, L.E. Sunscreen application by photosensitive patients is inadequate for protection. Br. J. Dermatol. 140, 255-258 (1999).
35. Azurdia, R.M., Pagliaro, J.A. and Rhodes, L.E. Sunscreen application technique in photosensitive patients: a quantitative assessment of the effect of education. Photodermatol. Photoimmunol. Photomed. 16, 53-56 (2000).
36. Sayre, R.M., Powell, J. and Rheins, L.A. Product application technique alters the sun protection factor. Photodermatol. Photoimmunol. Photomed. 8, 222-224 (1991).
37. Brown, S. and Diffey, B.L. The effect of applied thickness on sunscreen protection. In vivo and in vitro studies. Photochem. Photobiol. 44, 509-513 (1986).
38. Pruim, B. and Green, A. Photobiological aspects of sunscreen re-application. Aus. J. Dermatol. 40, 14-18 (1999).
39. Sarveija, V., Risk, S. and Benson, H. Skin penetration and systemic absorption of sunscreens after topical application. J. Am. Acad. Dermatol. 50, Supplement Poster 288 (1999).
40. Chatelain, E., Gabard, B. and Surber, C. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol. Appl. Skin Physiol. 16, 28-35 (2003).
41. Serpone, N., Salinaro, A., Emeline, A.V. et al. An in vitro systematic spectroscopic examination of the photostabilites of a random set of commercial sunscreen lotions and their chemical UVB/UVA active agents. Photochem. Photobiol. Sci. 1, 970-981 (2002).
42. Lott, D.L., Stanfleld, J., Sayre. R.M. and Dowdy, J.C. Uniformity of sunscreen product application: a problem in testing, a problem for consumers. Photodermatol. Photoimmunol. Photomed. 19, 17-20 (2003).
43. Tripp, C.S., Bloome, E.A.C.. Chinn, K.S. et al. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Invest. Dermatol. 121, 853-861 (2003).
44. British Photodermatology Group Photopatch testing - methods and indications. Br. J. Dermatol. 136, 371-376 (1997).